Tag: approves
First and only FDA-approved fixed-dose, triple-combination topical treatment LAVAL, QC / ACCESSWIRE / October 20, 2023 / Bausch Health Companies Inc. (NYSE:BHC) (TSX:BHC) (“Bausch Health”) and its dermatology business, Ortho Dermatologics, today announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application for CABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide) […]
Just a year after the U.S. Food and Drug Administration (FDA) approved the first treatment for severe alopecia areata, the federal agency has approved a second treatment for the disfiguring skin disease — both the result of pioneering research by the same Yale dermatologist. On June 23, the FDA announced its approval for the use […]
FRIDAY, May 19, 2023 (HealthDay News) — Patients with Crohn disease have a new treatment option, following U.S. Food and Drug Administration approval of Rinvoq (upadacitinib). Rinvoq is meant to treat adults with moderately to severely active Crohn disease who have not had success with tumor necrosis factor blockers. The daily pill is the first […]
The Food and Drug Administration has approved a first-of-its-kind treatment for vitiligo, a condition that causes patches of discoloration on the skin and, currently, has few other therapeutic options. The treatment, known as ruxolitinib, is now the only one approved in the U.S. to repigment skin in people with the most common, “nonsegmental” form of […]